Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Figueroa

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Cancer Cell|July 5, 2011
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformationKelly Moran-Crusio, Linsey Reavie, Alan Shih, et al.
Cell Reports|October 2, 2025
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activationTiffany E Leesang, John P Brabson, Yoon Sing Yap, et al.
Blood|July 30, 2025
XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid MalignanciesTraci L Kruer, Ariel Quintana-Gonzalez, Hannah L Newman, et al.
Cell|August 22, 2017
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia ProgressionLuisa Cimmino, Igor Dolgalev, Yubao Wang, et al.
Nature|July 6, 2012
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigeneticsMasato Sasaki, Christiane B Knobbe, Joshua C Munger, et al.
Plos Genetics|June 28, 2012
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemiaAltuna Akalin, Francine E Garrett-Bakelman, Matthias Kormaksson, et al.
Blood|March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMMLMargaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Cell Reports|February 27, 2023
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemiaJohn P Brabson, Tiffany Leesang, Yoon Sing Yap, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Cancer Cell|July 5, 2011
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformationKelly Moran-Crusio, Linsey Reavie, Alan Shih, et al.
Cell Reports|October 2, 2025
Retinoic acid and ascorbate synergize to suppress myeloid leukemia via TET2 activationTiffany E Leesang, John P Brabson, Yoon Sing Yap, et al.
Blood|July 30, 2025
XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid MalignanciesTraci L Kruer, Ariel Quintana-Gonzalez, Hannah L Newman, et al.
Cell|August 22, 2017
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia ProgressionLuisa Cimmino, Igor Dolgalev, Yubao Wang, et al.
Nature|July 6, 2012
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigeneticsMasato Sasaki, Christiane B Knobbe, Joshua C Munger, et al.
Plos Genetics|June 28, 2012
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemiaAltuna Akalin, Francine E Garrett-Bakelman, Matthias Kormaksson, et al.
Blood|March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMMLMargaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Cell Reports|February 27, 2023
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemiaJohn P Brabson, Tiffany Leesang, Yoon Sing Yap, et al.
Cancer Cell|December 7, 2010
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiationMaria E Figueroa, Omar Abdel-Wahab, Chao Lu, et al.
Pageof 9